Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Fortive Stock Up 0.4 %
Shares of FTV Stock traded up $0.29 on Thursday, hitting $68.33. 978,380 shares of the stock were exchanged, compared to its average volume of 2,778,736. The company has a current ratio of 0.94, a quick ratio of 0.73 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $24.30 billion, a P/E ratio of 37.77, a price-to-earnings-growth ratio of 2.35 and a beta of 1.16. Fortive has a fifty-two week low of $52.47 and a fifty-two week high of $79.87. The business has a 50-day moving average of $58.91 and a 200 day moving average of $60.38.
Fortive (NYSE:FTV - Get Rating) last posted its quarterly earnings data on Thursday, July 28th. The technology company reported $0.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.41 billion. Fortive had a net margin of 11.86% and a return on equity of 11.25%. The firm's revenue was up 10.9% compared to the same quarter last year. During the same period last year, the company earned $0.66 earnings per share. Equities analysts anticipate that Fortive will post 3.11 EPS for the current year.
Analysts Set New Price Targets
Several analysts have recently commented on the stock. StockNews.com raised shares of Fortive from a "hold" rating to a "buy" rating in a research note on Monday, August 1st. Wells Fargo & Company lifted their price objective on Fortive from $57.00 to $63.00 and gave the stock an "equal weight" rating in a research report on Monday, August 1st. Citigroup raised their target price on shares of Fortive from $69.00 to $72.00 in a research note on Friday, July 29th. Cowen cut their price objective on shares of Fortive from $80.00 to $70.00 and set a "market perform" rating on the stock in a report on Thursday, June 2nd. Finally, Credit Suisse Group set a $74.00 target price on Fortive in a research report on Tuesday, July 19th. Six equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $72.64.